查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1391160

2024 年数位治疗全球市场报告

Digital Therapeutics Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

随着智慧型手机和平板电脑设备的快速普及，以及医疗应用程式的预期普及，数位治疗市场预计在可预见的未来将继续成长。使用智慧型手机和平板电脑的医疗应用程式的普及带来了许多好处，包括减少用药错误、促进预防性护理以及提高人员分配的准确性。根据英国非营利组织GSMA（Groupe Speciale Mobile Association）发布的《2023年行动网路连线状况报告》，到2022年，全球一半以上（54%）的人口将拥有智慧型手机。智慧型手机的普及是数位治疗市场的关键驱动力，创造了有利于创新治疗性介入发展的环境。

2023 年数位治疗市场最大的地区是北美。预计亚太地区将成为预测期内成长最快的地区。数位治疗市场分析报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章数位治疗市场特点

第三章数位治疗市场趋势与策略

第四章数位治疗市场－宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章全球数位治疗市场的规模与成长

  • 全球数位治疗市场的驱动与抑制因素
    • 市场驱动力
    • 市场抑制因素
  • 2018-2023年全球数位治疗市场规模实绩与成长
  • 全球数位治疗市场规模与成长预测，2023-2028、2033

第六章数位治疗市场区隔

  • 全球数位治疗市场，按产品、实绩和预测细分，2018-2023、2023-2028、2033
  • 软体
  • 装置
  • 全球数位治疗市场，依销售管道细分，实绩与预测，2018-2023、2023-2028、2033
  • B2B（B2B）
  • 企业对消费者 (B2C)
  • 全球数位治疗市场，按应用、实绩和预测细分，2018-2023、2023-2028、2033
  • 预防性使用
  • 治疗或护理相关用途

第七章数位治疗市场区域与国家分析

  • 全球数位治疗市场，按地区、实绩和预测，2018-2023、2023-2028、2033
  • 全球数位治疗市场，依国家、实绩及预测，2018-2023、2023-2028、2033

第八章亚太数位治疗市场

第九章中国数位治疗市场

第十章 印度数位治疗市场

第十一章 日本数位治疗市场

第十二章澳洲数位治疗市场

第十三章印尼数位治疗市场

第14章韩国数位治疗市场

第十五章西欧数位治疗市场

第十六章英国数位治疗市场

第十七章 德国数位治疗市场

第十八章 法国数位治疗市场

第十九章义大利数位治疗市场

第20章 西班牙数位治疗市场

第21章东欧数位治疗市场

第22章 俄罗斯数位治疗市场

第23章 北美数位治疗市场

第24章美国数位治疗市场

第25章加拿大数位治疗市场

第26章南美数位治疗市场

第27章巴西数位治疗市场

第28章中东数位治疗市场

第29章非洲数位治疗市场

第30章数位治疗市场竞争形势及公司概况

  • 数位治疗市场竞争形势
  • 数位治疗市场公司概况
    • Omada Health Inc.
    • WellDoc Inc.
    • 2Morrow Inc.
    • Livongo Health
    • Propeller Health

第31章全球数位治疗市场的竞争基准化分析

第32章全球数位治疗市场竞争仪表板

第33章数位治疗市场的重大併购

第34章数位治疗市场未来展望及潜力分析

第35章附录

简介目录
Product Code: r9520

“Digital Therapeutics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The digital therapeutics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Software; Devices
  • 2) By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)
  • 3) By Application: Preventive Applications; Treatment Or Care-Related Applications
  • Companies Mentioned: Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Livongo Health; Propeller Health
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Digital therapeutics (DTx) represent products that deliver evidence-based therapeutic treatments to patients through sophisticated software applications. These applications aim to prevent, manage, or treat various medical ailments or diseases.

The primary categories of digital therapeutics products encompass devices and software. Digital therapeutics devices offer interventions for the prevention, management, or treatment of diseases or medical disorders. This may involve sensors utilized to monitor medication usage and location data. The sales channels for digital therapeutics include both business-to-business (B2B) and business-to-consumer (B2C). Digital therapeutics find applications in both preventive and treatment or care-related contexts.

The digital therapeutics market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics market statistics, including digital therapeutics industry global market size, regional shares, competitors with a digital therapeutics market share, detailed digital therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics industry. This digital therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics market size has grown exponentially in recent years. It will grow from $7.05 billion in 2023 to $8.93 billion in 2024 at a compound annual growth rate (CAGR) of 26.7%. The growth in the historic period of digital therapeutics can be attributed to factors such as the aging population, the prevalence of chronic diseases, increased adoption of digital health solutions, concerns about healthcare costs and efficiency, the rise of remote patient monitoring, and the demand induced by the COVID-19 pandemic.

The digital therapeutics market size is expected to see exponential growth in the next few years. It will grow to $23.49 billion in 2028 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period for digital therapeutics can be attributed to the increasing adoption of personalized medicine, a focus on health data interoperability, the shift towards value-based care models, a growing emphasis on mental health and well-being, efforts to improve healthcare access and equity, an increased focus on cybersecurity and data protection, and a rising demand for population health management. Major trends in the forecast period include the expansion of IoT devices and sensors in healthcare, the integration of artificial intelligence, the rise of wearable health technology, ongoing technological advancements, and continuous product innovations.

The anticipated surge in the use of smartphones and tablets, complemented by the widespread adoption of healthcare apps, is expected to drive the growth of the digital therapeutics market in the foreseeable future. The prevalence of smartphones and tablet-based healthcare apps brings about numerous advantages, including a reduction in medication errors, facilitating preventive care, and improving staffing accuracy. According to the State of Mobile Internet Connectivity Report 2023 by Groupe Speciale Mobile Association (GSMA), a UK-based non-profit organization, the year 2022 saw more than half of the world's population (54%) owning smartphones. This widespread use of smartphones is a significant driver for the digital therapeutics market, fostering a conducive environment for the growth of innovative therapeutic interventions.

The growing incidence of chronic diseases is poised to be a key driver propelling the expansion of the digital therapeutics market. Chronic diseases, characterized by long-lasting conditions requiring extended medical attention, significantly impact individuals' daily lives. Digital therapeutics, as software-based interventions, offer evidence-based therapeutic solutions to enhance the management of chronic diseases, providing patients with additional treatment options. Notably, data from the Centers for Disease Control and Prevention in July 2022 highlighted that six out of ten adults in the US are affected by chronic diseases, with four out of ten adults experiencing more than two chronic conditions such as heart disease, diabetes, and chronic lung diseases. This prevalence of chronic diseases contributes substantially to the growth trajectory of the digital therapeutics market.

An emerging trend in the digital therapeutics market is technological innovation, with major industry players focusing on developing advanced solutions to strengthen their market presence. Boehringer Ingelheim, a leading pharmaceutical company based in Germany, and Click Pharmaceuticals, a US-based prescription digital therapeutics business, have entered into a collaboration to develop and commercialize a digital medication for schizophrenia patients. This collaboration, valued at over $500 million, underscores the commitment to leveraging technological advancements. The proposed treatment, CT-155, will be a mobile app developed on Click's technology platform, showcasing the integration of innovative digital solutions in the field of therapeutics. This strategic partnership reflects the industry's dedication to advancing and integrating technology to enhance treatment options and patient outcomes in the digital therapeutics market.

Major players in the digital therapeutics market are actively developing innovative ordering, dispensing, and fulfillment platforms to cater to patients dealing with chronic diseases. An exemplar in this regard is DTx Connect, a platform designed to deliver therapeutic interventions directly to patients through software, addressing a spectrum of diseases and disorders including mental health issues and diabetes. In July 2022, AmerisourceBergen, a pharmaceutical solutions organization based in the US, introduced DTx Connect, a fully integrated platform for ordering, dispensing, and fulfillment. Key features of the DTx Connect platform include seamless integration with electronic medical records (EMR), enabling physicians to access and prescribe both prescription and non-prescription digital therapeutics through their e-prescribing workflow. The platform also facilitates the monitoring of patient fulfillment, streamlining the process for healthcare providers.

In July 2023, Big Health acquired Limbix for an undisclosed amount, aiming to expand its existing product portfolio. Big Health's product range includes Sleepio for insomnia and Daylight for anxiety, and with the acquisition of Limbix, it incorporates SparkRx and another teenage medication in development for anxiety. Limbix, a US-based provider of digital therapeutics, adds valuable assets to Big Health's offerings, enhancing its capabilities in providing a comprehensive suite of digital therapeutic solutions. This acquisition reflects the dynamic landscape of the digital therapeutics market, characterized by strategic moves to broaden product portfolios and meet the diverse needs of patients dealing with various health conditions.

Major companies operating in the digital therapeutics market include Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health, Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Mango Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic PLC, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Riva, Xealth, CogniFit Ltd.

North America was the largest region in the digital therapeutics market in 2023. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutic market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the digital therapeutics market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The digital therapeutics market consists of sales of products to treat a disease, manage a condition, and improve a health function. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Digital Therapeutics Market Characteristics

3. Digital Therapeutics Market Trends And Strategies

4. Digital Therapeutics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Digital Therapeutics Market Size and Growth

  • 5.1. Global Digital Therapeutics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Digital Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Digital Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Digital Therapeutics Market Segmentation

  • 6.1. Global Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Software
  • Devices
  • 6.2. Global Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Business-To-Business (B2B)
  • Business-To-Consumers (B2C)
  • 6.3. Global Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Preventive Applications
  • Treatment Or Care-Related Applications

7. Digital Therapeutics Market Regional And Country Analysis

  • 7.1. Global Digital Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Digital Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Digital Therapeutics Market

  • 8.1. Asia-Pacific Digital Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Digital Therapeutics Market

  • 9.1. China Digital Therapeutics Market Overview
  • 9.2. China Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Digital Therapeutics Market

  • 10.1. India Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Digital Therapeutics Market

  • 11.1. Japan Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Digital Therapeutics Market

  • 12.1. Australia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Digital Therapeutics Market

  • 13.1. Indonesia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Digital Therapeutics Market

  • 14.1. South Korea Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Digital Therapeutics Market

  • 15.1. Western Europe Digital Therapeutics Market Overview
  • 15.2. Western Europe Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Digital Therapeutics Market

  • 16.1. UK Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Digital Therapeutics Market

  • 17.1. Germany Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Digital Therapeutics Market

  • 18.5. France Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Digital Therapeutics Market

  • 19.9. Italy Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Digital Therapeutics Market

  • 20.13. Spain Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Digital Therapeutics Market

  • 21.1. Eastern Europe Digital Therapeutics Market Overview
  • 21.2. Eastern Europe Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Digital Therapeutics Market

  • 22.1. Russia Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Digital Therapeutics Market

  • 23.1. North America Digital Therapeutics Market Overview
  • 23.2. North America Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Digital Therapeutics Market

  • 24.1. USA Digital Therapeutics Market Overview
  • 24.2. USA Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Digital Therapeutics Market

  • 25.1. Canada Digital Therapeutics Market Overview
  • 25.2. Canada Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Digital Therapeutics Market

  • 26.1. South America Digital Therapeutics Market Overview
  • 26.2. South America Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Digital Therapeutics Market

  • 27.1. Brazil Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Digital Therapeutics Market

  • 28.1. Middle East Digital Therapeutics Market Overview
  • 28.2. Middle East Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Digital Therapeutics Market

  • 29.1. Africa Digital Therapeutics Market Overview
  • 29.2. Africa Digital Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Digital Therapeutics Market, Segmentation By Sales Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Digital Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Digital Therapeutics Market Competitive Landscape And Company Profiles

  • 30.1. Digital Therapeutics Market Competitive Landscape
  • 30.2. Digital Therapeutics Market Company Profiles
    • 30.2.1. Omada Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. WellDoc Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. 2Morrow Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Livongo Health
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Propeller Health
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Digital Therapeutics Market Competitive Benchmarking

32. Global Digital Therapeutics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics Market

34. Digital Therapeutics Market Future Outlook and Potential Analysis

  • 34.1 Digital Therapeutics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Digital Therapeutics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Digital Therapeutics Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer